The company's principal activities are to discover, develop and commercialize proprietary pharmaceuticals based on naturally occurring molecule nitric oxide. The company uses nitric oxide biology and chemistry to develop novel drugs and also the existing drugs. The operations of the company are carried out in the United States.
